204 results
Page 6 of 11
6-K
EX-99.1
vk6dt0v6735
12 Nov 20
Condensed Consolidated Interim Financial Statements of
4:09pm
6-K
EX-99.1
sg7akscr
12 Nov 20
BELLUS Health Reports Third Quarter 2020 Financial Results and Business Highlights
7:01am
6-K
EX-99.1
bueoh 9drn
10 Nov 20
BELLUS Health to Participate in Jefferies Virtual London Healthcare Conference
7:00am
6-K
EX-99.2
r1i72nv34
20 Oct 20
As Representatives of the several Underwriters
4:43pm
SUPPL
stwg qq5cdl
20 Oct 20
Supplemental materials (foreign)
12:00am
SUPPL
cqyphh
19 Oct 20
Supplemental materials (foreign)
5:12pm
6-K
EX-99.1
9earc19
19 Oct 20
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:57pm
6-K
44h1f
8 Sep 20
BELLUS Health Announces Design for its Phase 2b Trial with BLU-5937 in Refractory Chronic Cough
7:00am
6-K
EX-99.1
7ptrp2x n4rvk409kmw9
8 Sep 20
BELLUS Health Announces Design for its Phase 2b Trial with BLU-5937 in Refractory Chronic Cough
7:00am
6-K
EX-99.1
61tzeobm
3 Sep 20
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
EX-99.1
qebzbvf6fo xgu
13 Aug 20
Condensed Consolidated Interim Financial Statements of
4:01pm
6-K
EX-99.2
q3atom ywsbrmy9gqk8
13 Aug 20
Condensed Consolidated Interim Financial Statements of
4:01pm
6-K
EX-99.1
qj20x1dlc vb
13 Aug 20
BELLUS Health Reports Second Quarter 2020 Financial Results and Business Highlights
7:00am
6-K
EX-99.1
r97wnor6 q7hxfix9o8
6 Jul 20
BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
qmjrvq4iv0v6mt 51wm0
6 Jul 20
BELLUS Health Announces Topline Results from its Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
gsek8w63 l4s
28 May 20
BELLUS Health to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
7:00am
6-K
EX-99.2
953bg8bcnhby32z
14 May 20
Condensed Consolidated Interim Financial Statements of
5:12pm
6-K
EX-99.1
zgs5k 2a2mctm8ylyj
14 May 20
Condensed Consolidated Interim Financial Statements of
5:12pm
6-K
EX-99.1
r46ltqkrl qu
14 May 20
BELLUS Health Reports First Quarter 2020 Financial Results and Business Highlights, and Provides Updates on BLU-5937
5:00pm
6-K
pnk1k f46m
13 May 20
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment and the BLU-5937 Program
7:00am